A
Price
$113.94
Change
+$0.71 (+0.63%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
42.66B
20 days until earnings call
ARAY
Price
$1.32
Change
+$0.01 (+0.76%)
Updated
Aug 7, 04:24 PM (EDT)
Capitalization
244.95M
6 days until earnings call
Interact to see
Advertisement

A vs ARAY

Header iconA vs ARAY Comparison
Open Charts A vs ARAYBanner chart's image
Agilent Technologies
Price$113.94
Change+$0.71 (+0.63%)
Volume$14.88K
Capitalization42.66B
Accuray
Price$1.32
Change+$0.01 (+0.76%)
Volume$501
Capitalization244.95M
A vs ARAY Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. ARAY commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and ARAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (A: $113.23 vs. ARAY: $1.31)
Brand notoriety: A and ARAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 56% vs. ARAY: 38%
Market capitalization -- A: $42.66B vs. ARAY: $244.95M
A [@Medical Specialties] is valued at $42.66B. ARAY’s [@Medical Specialties] market capitalization is $244.95M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileARAY’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • ARAY’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than ARAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while ARAY’s TA Score has 4 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 5 bearish.
  • ARAY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ARAY is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -4.08% price change this week, while ARAY (@Medical Specialties) price change was -2.24% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.65%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was -3.32%.

Reported Earning Dates

A is expected to report earnings on Aug 27, 2025.

ARAY is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Medical Specialties (+0.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than ARAY($245M). A YTD gains are higher at: -15.357 vs. ARAY (-33.838). A has higher annual earnings (EBITDA): 1.69B vs. ARAY (5.93M). ARAY has less debt than A: ARAY (202M) vs A (2.56B). A has higher revenues than ARAY: A (6.74B) vs ARAY (447M).
AARAYA / ARAY
Capitalization42.7B245M17,429%
EBITDA1.69B5.93M28,490%
Gain YTD-15.357-33.83845%
P/E Ratio34.82N/A-
Revenue6.74B447M1,507%
Total CashN/A72.8M-
Total Debt2.56B202M1,265%
FUNDAMENTALS RATINGS
A vs ARAY: Fundamental Ratings
A
ARAY
OUTLOOK RATING
1..100
6772
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
86
Overvalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
4789
PRICE GROWTH RATING
1..100
6285
P/E GROWTH RATING
1..100
7244
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (19) in the Biotechnology industry is significantly better than the same rating for ARAY (86) in the Medical Specialties industry. This means that A’s stock grew significantly faster than ARAY’s over the last 12 months.

A's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as ARAY (100) in the Medical Specialties industry. This means that A’s stock grew similarly to ARAY’s over the last 12 months.

A's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for ARAY (89) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than ARAY’s over the last 12 months.

A's Price Growth Rating (62) in the Biotechnology industry is in the same range as ARAY (85) in the Medical Specialties industry. This means that A’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's P/E Growth Rating (44) in the Medical Specialties industry is in the same range as A (72) in the Biotechnology industry. This means that ARAY’s stock grew similarly to A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AARAY
RSI
ODDS (%)
Bearish Trend 2 days ago
46%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 7 days ago
60%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MIELY48.531.17
+2.47%
Mitsubishi Electric Corp.
OILRF0.26N/A
N/A
Oil Refineries Ltd.
STPGF0.89N/A
N/A
Steppe Gold Limited
VINO0.12N/A
N/A
Gaucho Group Holdings Inc.
WYNMF0.79N/A
N/A
Wynn Macau Ltd.

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with KIDS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then KIDS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
+0.77%
KIDS - ARAY
43%
Loosely correlated
-11.34%
ILMN - ARAY
42%
Loosely correlated
-3.41%
A - ARAY
41%
Loosely correlated
-1.44%
ICUI - ARAY
40%
Loosely correlated
-1.65%
ITGR - ARAY
39%
Loosely correlated
-2.19%
More